MR

Malliah Rajarathinam

Active Director Managing Director DIN 02100011
DIN 02100011 First appointment Dec 1995 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Dec 1995
Shareholding value •••• Premium profile

About Malliah Rajarathinam

Data last updated:

Malliah Rajarathinam is a Managing Director at Mmc Pharmaceuticals Limited (since 2016) and Director at Mmc Healthcare (Himachal Pradesh) Private Limited (since 2009). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹52.86 Cr; the largest is Mmc Pharmaceuticals Limited at ₹52.03 Cr (FY 2024). Earlier, Malliah Rajarathinam was a Whole-Time Director at Mmc Health Care Limited (2005–2018) and Director at Verax Lifesciences Private Limited (2014–2017) and 1 more.

DIN 02100011
Primary Designation Managing Director
Industry Pharma
First Appointment 06 Dec 1995
Oldest Company Age 30 yrs
Largest company Mmc Pharmaceuticals Limited · ₹52.03 Cr (FY 2024)
Combined revenue ₹52.86 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mmc Pharmaceuticals Limited U24100TN2016PLC104768
Managing Director18 Mar 20162016₹52.03 Cr (FY 2024)Active
Director22 Jul 20092004₹83.5 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mmc Health Care Limited U93090TN1996PLC034651
Whole-Time Director01 Apr 20051996₹39.60 Cr (FY 2024)Active
Verax Lifesciences Private Limited U36102HP2009PTC031136
Director07 Nov 20142009₹7.87 Cr (FY 2024)Active
Hepta Pharma Private Limited U24231TN1995PTC033732
Director06 Dec 19951995Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mmc Pharmaceuticals Limited
Hepta Pharma Private Limited
Mmc Healthcare (Himachal Pradesh) Private Limited
Mmc Health Care Limited
Premium access

Shareholding and investment profile for Malliah Rajarathinam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Malliah Rajarathinam

Malliah Rajarathinam currently holds 2 directorships: Mmc Pharmaceuticals Limited (Managing Director, since 18 Mar 2016, revenue ₹52.03 Cr (FY 2024)); Mmc Healthcare (Himachal Pradesh) Private Limited (Director, since 22 Jul 2009, revenue ₹83.5 Lakh (FY 2025)).

Malliah Rajarathinam was first appointed on 06 Dec 1995 as Director at Hepta Pharma Private Limited. The most recent appointment on record is 18 Mar 2016 at Mmc Pharmaceuticals Limited.

The 2 current companies of Malliah Rajarathinam that report revenue have a combined latest revenue of ₹52.86 Cr: Mmc Pharmaceuticals Limited ₹52.03 Cr (FY 2024); Mmc Healthcare (Himachal Pradesh) Private Limited ₹83.5 Lakh (FY 2025).

Malliah Rajarathinam held 3 earlier board appointments: Mmc Health Care Limited (Whole-Time Director, 01 Apr 2005 to 03 Aug 2018); Verax Lifesciences Private Limited (Director, 07 Nov 2014 to 16 Jan 2017); Hepta Pharma Private Limited (Director, from 06 Dec 1995).

The current boards of Malliah Rajarathinam's companies include Girijadevi Jayaraman (Mmc Pharmaceuticals Limited), Malliah Vidyavathi (Mmc Pharmaceuticals Limited), Rajarathinam Vallab Subash (Mmc Pharmaceuticals Limited), Shanthi (Mmc Pharmaceuticals Limited), Sureshbabu Makam (Mmc Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available